Rod Quilitz, PharmD, clinical pharmacist at Moffitt Cancer Center, speaks about invasive fungal infections in immunocompromised patients. In this 2013 update, he discusses risk factors that predisposes immunocompromised patients to IFIs, common fungal pathogens, and available antifungal agents. He discusses the impact of prolonged neutropenia and different levels of CD4 cell counts on susceptibility to fungal infections. Pathogens covered include Candida, Cryptococcus, Aspergillosis, Fusarium, and Zygomycosis. He discusses spectrum, efficacy, toxicity, and drug interactions for different antifungal agents, including the investigational Posaconazole.

IDPodcasts brings you essential updates in medical infectious diseases learning, brought to you from the University of South Florida’s Division of Infectious Disease.

Stay in touch! Download our app on the Itunes store or find us below:

Subscribe to our Youtube Channel: [ Ссылка ]
Visit us on our webpage: [ Ссылка ]
Follow us on Facebook: [ Ссылка ]

Tweet to us: [ Ссылка ]

свернуть